Description

Drug Classification:

Iron Sucrose Complex Injection belongs to the class of drugs known as iron supplements. This formulation delivers iron in the form of a stable complex with sucrose, ensuring optimal bioavailability and minimal risk of adverse reactions.

Formulations:

• Iron Sucrose Complex Injection:

• • Strength: Each liquid ampule contains 100 mg of Iron (as Iron Sucrose Complex).
  • Product Form: Injectable solution for intravenous administration.
  • Packing Specs: Available in packs of 5 liquid ampoules for convenient dosing and storage.

Indications:

Iron Sucrose Complex Injection is indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron preparations or who have a clinical need for rapid iron repletion. This product is particularly beneficial for individuals with chronic diseases such as chronic kidney disease or heart failure, where oral iron absorption may be impaired or insufficient to meet iron requirements.

Usage:

• Iron Sucrose Complex Injection should be administered under the supervision of a healthcare professional experienced in the management of iron deficiency anemia.
• The injection is intended for intravenous use only and should not be administered via other routes.
• Prior to administration, the liquid ampule should be visually inspected for particulate matter and discoloration. Any ampules showing signs of contamination should not be used.
• The injection should be administered at the recommended rate of infusion to minimize the risk of adverse reactions.

Dosage:

• The recommended dosage of Iron Sucrose Complex Injection is determined based on the patient’s iron deficit and hemoglobin levels, as well as their clinical response to treatment.
• Dosage adjustments may be necessary for patients with severe iron deficiency anemia or underlying medical conditions affecting iron metabolism.

Pharmacokinetics:

• Iron Sucrose Complex is a stable complex of iron and sucrose, designed to facilitate the controlled release of iron into the bloodstream.
• Following intravenous administration, Iron Sucrose Complex undergoes dissociation, releasing iron ions that bind to transferrin and are transported to the bone marrow for incorporation into hemoglobin.

Pharmacodynamics:

• Iron Sucrose Complex Injection replenishes iron stores and supports erythropoiesis, leading to an increase in hemoglobin levels and resolution of iron deficiency anemia.
• The controlled release of iron from the sucrose complex minimizes the risk of adverse effects associated with rapid iron infusion, such as hypotension or hypersensitivity reactions.

Side Effects:

• Common side effects associated with Iron Sucrose Complex Injection may include transient gastrointestinal disturbances, such as nausea, vomiting, or abdominal discomfort.
• Hypersensitivity reactions, including anaphylaxis, may occur rarely following intravenous administration of iron preparations. Patients should be monitored closely for signs of allergic reactions during and after infusion.

Trust in the efficacy and safety of Iron Sucrose Complex Injection from AIT Pharmaceuticals Division. With our dedication to patient care and pharmaceutical excellence, we strive to provide solutions that make a meaningful difference in the lives of individuals affected by iron deficiency anemia. For more information, please visit our website or consult your healthcare provider.